# InvestorNewsBreaks – Fifty 1 Labs, Inc. (OTC: FITY) and UAV Corp (OTC: UMAV) Announces Strategic Partnership and Intent to Acquire BioSpark AI to Advance Drug Repurposing

Fifty 1 Labs (OTC: FITY) announced a strategic partnership and intent to acquire Vancouver-based BioSpark AI Technologies Inc., a leader in AI and large language model technologies. The alliance merges BioSpark’s literature mining platform with Fifty1’s predictive modeling to extract real-world clinical insights at scale—unlocking overlooked therapeutic patterns for drug repurposing. The partnership will support rapid identification of new formulations focused on performance health and preventative care, with proprietary delivery systems. The move reinforces Fifty1 AI Labs’ vision to lead in AI-powered functional medicine by integrating structured clinical data with advanced Bayesian inference and human-AI collaboration.

 To view the full press release, visit https://ibn.fm/xhYyb

 About Fifty 1 Labs, Inc.

 Fifty 1 Labs, Inc. (OTC: FITY), a Nevada corporation based at 751 North Drive, Melbourne, FL 32934, is a holding company driving innovation in health, wellness, and biotechnology. FITY owns 100% of Genetic Networks LLC, a Delaware-based biotech firm founded in 2015 by Dr. Gennaro D’Urso. Genetic Networks, headquartered in Miami, Florida, develops the GeneScape platform, a yeast-based, whole-genome analysis tool that accelerates drug discovery for personalized medicine, biodefense, and wellness applications, with proven success serving major pharma clients like Bristol Myers Squibb. FITY also wholly owns 51, LLC, its sports nutrition subsidiary offering a premium line of supplements—including pre-workout formulas, BCAAs, ION+ Electrolyte Formula, Turmeric Gummies, and Ashwagandha Gummies—designed to enhance athletic performance, recovery, and overall health. The Quickness, Astound NMN, and Drago Knives have been merged out of the company and are no longer part of Fifty 1 Labs, Inc., sharpening FITY’s focus on biotech and wellness synergies to empower individuals and organizations worldwide.

 For more information, visit the company’s website at https://fifty1labs.com/

 About InvestorWire

 InvestorWire (“IW”) is a specialized communications platform with a focus on advanced wire-grade press release syndication for private and public companies and the investment community. It is one of 60+ brands within the Dynamic Brand Portfolio @ IBN that delivers: (1) access to a vast network of wire solutions via InvestorWire to efficiently and effectively reach a myriad of target markets, demographics and diverse industries; (2) article and editorial syndication to 5,000+ outlets; (3) enhanced press release enhancement to ensure maximum impact; (4) social media distribution via IBN to millions of social media followers; and (5) a full array of tailored corporate communications solutions. With broad reach and a seasoned team of contributing journalists and writers, IW is uniquely positioned to best serve private and public companies that want to reach a wide audience of investors, influencers, consumers, journalists and the general public. By cutting through the overload of information in today’s market, IW brings its clients unparalleled recognition and brand awareness. IW is where breaking news, insightful content and actionable information converge.

 For more information, please visit https://www.InvestorWire.com

 Please see full terms of use and disclaimers on the InvestorWire website applicable to all content provided by IW, wherever published or re-published: https://www.InvestorWire.com/Disclaimer

 InvestorWireLos Angeles, CAwww.InvestorWire.com310.299.1717 OfficeEditor@InvestorWire.com

 InvestorWire is powered by IBN 

---

[Original/Source Press Release](https://rss.investorbrandnetwork.com/iw/investornewsbreaks-fifty-1-labs-inc-otc-fity-and-uav-corp-otc-umav-announces-strategic-partnership-and-intent-to-acquire-biospark-ai-to-advance-drug-repurposing/)
                    

[Newsramp.com TLDR](https://newsramp.com/curated-news/fifty-1-labs-partners-with-biospark-ai-to-revolutionize-drug-repurposing/b279d22f8a1af4352783a8bdba6cdf64) 

 



[Reddit Post](https://www.reddit.com/r/HealthCareNewsInfo/comments/1m2bosh/fifty_1_labs_partners_with_biospark_ai_to/) 



![Blockchain Registration](https://cdn.newsramp.app/ibn/qrcode/257/17/cakeKof8.webp)